These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5681485)

  • 1. Cytological, cytometric and cytochemical studies in myeloma.
    Hayhoe FG; Neuman Z
    Br J Haematol; 1968 Sep; 15(3):320-1. PubMed ID: 5681485
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytochemical examination of human bone marrow plasmocytes.
    Malasková V; Fuksová J; Lindnerová G
    Haematologia (Budap); 1971; 5(4):393-406. PubMed ID: 4260356
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytochemical characteristics of lymphoid cells in patients with multiple myeloma].
    Lugovskaia SA
    Lab Delo; 1982; (11):643-6. PubMed ID: 6184523
    [No Abstract]   [Full Text] [Related]  

  • 4. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
    Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
    Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Findings on the bone marrow synthesis of serum and urinary paraproteins in a plasmacytoma patient].
    PIGNATARO L; MARINONI GF; BONITO G; BOLOGNESI G; RIZZA O
    Boll Soc Ital Biol Sper; 1961 May; 37():421-3. PubMed ID: 13735681
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple myeloma masquerading as metastatic breast carcinoma.
    Saroha V; Mandal S; Singh T
    Indian J Pathol Microbiol; 2011; 54(3):657-8. PubMed ID: 21934260
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic B cell malignancies and bone marrow microenvironment.
    Ghia P; Granziero L; Chilosi M; Caligaris-Cappio F
    Semin Cancer Biol; 2002 Apr; 12(2):149-55. PubMed ID: 12027587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
    Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
    Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Unspecific esterases and acid phosphatase in plasmacytomas].
    Löffler H
    Blut; 1967 Sep; 15(6):330-5. PubMed ID: 4167220
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron in neoplastic cells of plasma cell myeloma.
    Vidulich K; Hanks D; Etzell JE
    Am J Hematol; 2006 Mar; 81(3):216-7. PubMed ID: 16493624
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mutual interaction between myeloma cells and bone marrow microenvironment].
    Abe M
    Rinsho Ketsueki; 2009 Jun; 50(6):453-60. PubMed ID: 19571504
    [No Abstract]   [Full Text] [Related]  

  • 12. Histomorphology of multiple myeloma on bone marrow biopsy.
    Singhal N; Singh T; Singh ZN; Shome DK; Gaiha M
    Indian J Pathol Microbiol; 2004 Jul; 47(3):359-63. PubMed ID: 16295424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytochemical study of neoplastic and reactive plasmocytes].
    Podzun IE
    Medicina (B Aires); 1967; 27(4):235-8. PubMed ID: 4174471
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
    Yeh YA; Pappas AA; Flick JT; Butch AW
    Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow plasma cell infiltration in multiple myeloma.
    de Gramont A; Benitez O; Smadja N; Brissaud P; Sirinelli A; Hubert D; Krulik M; Debray J
    Br J Haematol; 1984 Jun; 57(2):351-3. PubMed ID: 6733051
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward development of a novel NOD/SCID-based in vivo strategy to model multiple myeloma pathogenesis.
    Bueno C; Lopes LF; Greaves M; Menendez P
    Exp Hematol; 2007 Oct; 35(10):1477-8. PubMed ID: 17681665
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative studies of bone marrow smears and bone marrow biopsy in diffuse plasmocytoma].
    PAPAGEORGIOU A; SCHMITT-ROHDE JM
    Dtsch Arch Klin Med; 1960; 206():574-82. PubMed ID: 13732604
    [No Abstract]   [Full Text] [Related]  

  • 19. Dehydroepiandrosterone can inhibit the proliferation of myeloma cells and the interleukin-6 production of bone marrow mononuclear cells from patients with myeloma.
    Liu S; Ishikawa H; Li FJ; Ma Z; Otsuyama K; Asaoku H; Abroun S; Zheng X; Tsuyama N; Obata M; Kawano MM
    Cancer Res; 2005 Mar; 65(6):2269-76. PubMed ID: 15781640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasmocytes et globulines gamma].
    MONNIER P; ARNAVIELHE-BONY M; SANY C; GARRIGUE J
    Ann Biol Clin (Paris); 1958; 16(7-9):448-58. PubMed ID: 13595266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.